Here, increased CaV1.2E9* channels produced enhanced channel functioning in diabetic hearts, we think by targeting CaV1.2 exon 9* or its regulatory factor Rbfox2 is possibly an optimal idea to manage DCM, which requires further investigations. This evidence concerns the gene RBFOX2 and familial dilated cardiomyopathy.